Literature DB >> 7013555

Identification of a basement membrane proteoglycan in exfoliation material.

J P Harnisch, H J Barrach, J R Hassell, P K Sinha.   

Abstract

We have used the indirect immunperoxidase technique to examine the exfoliation syndrome and can demonstrate that the fibrils so typically found in this disease certainly contain basement membrane proteoglycans. This finding is interesting for two reasons: 1. For the first time, an electron-microscopical technique is described that is able to identify one protein component of the exfoliation material. 2. The fact that the basement membrane proteoglycans are present in the exfoliation material supports the hypothesis that this disease is caused by a disturbance in the biosynthesis of the basement membrane.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7013555     DOI: 10.1007/bf00407666

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  10 in total

1.  Enzyme-labeled antibodies for the light and electron microscopic localization of tissue antigens.

Authors:  P K Nakane; G B Pierce
Journal:  J Cell Biol       Date:  1967-05       Impact factor: 10.539

2.  Electron-microscopic study of pseudo-exfoliation of the lens capsule.

Authors:  Y Takei; K Mizuno
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-03-07

3.  Exfoliation material in different sections of the eye.

Authors:  J P Harnisch
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-09-28

4.  Symposium on pseudocapsular exfoliation and glaucoma. Fibrillopathia epitheliocapsularis: review of the nature and origin of pseudoexfoliative deposits.

Authors:  D H Dickson; M S Ramsey
Journal:  Trans Ophthalmol Soc U K       Date:  1979-07

5.  Pseudo-exfoliation material--an amyloid-like substance.

Authors:  A Ringvold; G Husby
Journal:  Exp Eye Res       Date:  1973-11-11       Impact factor: 3.467

6.  Aggregation of cartilage proteoglycans. 3. Characteristics of the proteins isolated from trypsin digests of aggregates.

Authors:  D Heinegård; V C Hascall
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

7.  A preliminary report on the amino acid composition of the pseudo-exfoliation material (PE material).

Authors:  A Ringvold
Journal:  Exp Eye Res       Date:  1973-01-01       Impact factor: 3.467

8.  [Electron microscopic studies in the pseudoexfoliative syndrome].

Authors:  D S Krol'; N I Zatulina
Journal:  Oftalmol Zh       Date:  1971

9.  Ultrastructure of exfoliation material (busacca deposits).

Authors:  A Ringvold
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1970

10.  Pseudo-exfoliation material on the anterior lens surface. Demonstration and examination of an interfibrillar ground substance.

Authors:  M Davanger; O O Pedersen
Journal:  Acta Ophthalmol (Copenh)       Date:  1975-03
  10 in total
  6 in total

1.  Immunogold localisation of laminin in normal and exfoliative iris.

Authors:  A G Konstas; G E Marshall; W R Lee
Journal:  Br J Ophthalmol       Date:  1990-08       Impact factor: 4.638

2.  Pseudoexfoliative material contains an elastic microfibrillar-associated glycoprotein.

Authors:  B W Streeten; S A Gibson; A J Dark
Journal:  Trans Am Ophthalmol Soc       Date:  1986

3.  Exfoliation syndrome and occludable angles.

Authors:  R Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  1994

4.  Probability of the presence of glycosaminoglycans in aqueous humor.

Authors:  H Baba
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

5.  Histochemical and polarization optical investigation for glycosaminoglycans in exfoliation syndrome.

Authors:  H Baba
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

6.  Geographic and climatic factors associated with exfoliation syndrome.

Authors:  Joshua D Stein; Louis R Pasquale; Nidhi Talwar; Denise S Kim; David M Reed; Bin Nan; Jae Hee Kang; Janey L Wiggs; Julia E Richards
Journal:  Arch Ophthalmol       Date:  2011-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.